Why Mesh Revision Surgery Is Challenging
Revision surgery for hernia mesh complications is substantially more difficult than the initial hernia repair. The original mesh becomes incorporated into surrounding tissue through fibrotic encapsulation — essentially, scar tissue grows into and around the mesh, making it inseparable from the abdominal wall, peritoneum, and in complicated cases, the bowel or bladder. A surgeon performing explantation must carefully dissect the mesh free from these adherent structures while avoiding injury to vital organs. The complexity increases dramatically when the mesh has adhered to bowel — the risk of inadvertent enterotomy (bowel puncture) during adhesiolysis is significant.
Types of Revision Procedures
Adhesiolysis is the surgical separation of adhesion bands connecting the mesh to adjacent structures. It may be performed laparoscopically for limited adhesions or require open surgery for extensive involvement. Partial mesh removal involves excising only the portion of the mesh causing symptoms while leaving well-incorporated portions in place — this approach carries the risk of leaving a nidus of infection or continued inflammation. Complete mesh explantation (meshectomy) removes the entire implant and is the definitive treatment for infected mesh and severe migration cases. It is the highest-risk procedure and may require bowel resection if the bowel is non-viable due to adhesion-related ischemia.
Costs and Recovery of Revision Surgery
Hernia mesh revision surgery costs range from $30,000 for a straightforward laparoscopic adhesiolysis to over $150,000 for complex open explantation with bowel resection and reconstruction. Hospital stays typically range from 3 to 14 days depending on complexity. Recovery periods extend from 4 weeks for minor procedures to 3 to 6 months for major reconstructions. Many patients require a period of home health care, wound nursing visits, and extended physical therapy after complex revisions. These costs are fully compensable as economic damages in hernia mesh litigation.
Hernia Recurrence After Revision
After explantation of the original synthetic mesh, surgeons must address the hernia defect that remains. Options include re-repair with biological mesh (acellular dermal matrix derived from human or animal tissue, which is less prone to infection and adhesion but more expensive), primary suture repair without mesh (higher recurrence rate), or component separation techniques for large defects. Many patients require a staged approach — temporary closure followed by definitive repair months later after wound healing is complete. The need for additional surgeries compounds both the physical burden and the legal damages available to the plaintiff.
Frequently Asked Questions
Related Pages
Davol and C.R. Bard Hernia Mesh Products
Davol Inc. and its parent C.R. Bard (now Becton Dickinson) manufactured the largest portfolio of recalled and litigation-linked hernia mesh products in the United States. Products including 3DMax, Ventralex ST, and the recalled Composix Kugel are at the center of MDL 2846 — one of the largest active medical device MDLs in federal court.
Hernia Mesh Infection Claims
Hernia mesh infection is a devastating complication because bacteria colonize the mesh material in treatment-resistant biofilms, usually requiring complete surgical removal. Mesh design characteristics — including pore size, material composition, and surface coatings — directly affect infection susceptibility, creating strong product liability theories.
Hernia Mesh Settlements — What to Expect
Hernia mesh mass tort settlements are structured as tiered grids based on injury severity, number of revision surgeries, and individual case factors. Understanding how settlement grids work and what factors increase your tier placement helps you evaluate your claim and avoid accepting inadequate offers.
Hernia Mesh Evidence — Building Your Claim
A strong hernia mesh claim rests on three evidentiary pillars: confirmed product identification (which specific mesh was implanted), documented complications in medical records, and expert opinions causally linking the mesh to the injuries. Gathering and preserving this evidence from the moment complications are identified is the single most important step a potential claimant can take.
Ethicon and Johnson and Johnson Hernia Mesh
Ethicon, a Johnson and Johnson subsidiary, manufactured the Physiomesh Flexible Composite — voluntarily withdrawn from global markets in May 2016 after independent registry data revealed reoperation rates two to three times higher than comparator meshes. Ethicon Physiomesh and related product claims are consolidated in MDL 2753 in the District of New Jersey and MCL 616 in New Jersey Superior Court.
Hernia Mesh Complications — What Can Go Wrong
Defective hernia mesh can cause a spectrum of complications from painful but treatable infections to catastrophic bowel perforation and sepsis. Understanding which complications are associated with mesh defects — versus routine surgical risks — is essential for evaluating whether a legal claim exists.
Hernia Mesh Recall History — What the FDA Found
The FDA has issued safety communications, ordered 522 post-market surveillance studies, and presided over multiple hernia mesh recalls. The regulatory history establishes that manufacturers had notice of mesh complications well before many patients were implanted — a critical element of failure-to-warn and design defect claims.
Inguinal Hernia Mesh Claims
Inguinal hernia mesh repairs are the most common hernia surgery in the United States, accounting for approximately 800,000 procedures annually. The inguinal region's proximity to critical nerves and spermatic cord structures makes mesh complications in this location particularly likely to cause chronic, debilitating pain.
Ventral Hernia Mesh Claims
Ventral hernias — including incisional hernias following prior abdominal surgeries — are typically repaired with large sheets of synthetic mesh placed intra-abdominally or in the retromuscular space. The large surface area of ventral mesh in contact with bowel creates significant risk of adhesion, migration, and bowel obstruction.
Hernia Mesh MDL 2846 — What You Need to Know
MDL 2846 in the Southern District of Ohio is the federal coordination for all Davol/C.R. Bard hernia mesh cases. With over 20,000 cases and ongoing bellwether trials, understanding how the MDL works is essential for any potential claimant navigating this litigation.
Hernia Mesh Chronic Pain — Inguinodynia Claims
Chronic groin pain (inguinodynia) following hernia mesh repair affects an estimated 10 to 30 percent of patients in some surgical registry studies and is the most common basis for hernia mesh legal claims. Nerve entrapment by mesh fixation devices and mesh contracture are the primary mechanisms. Chronic pain claims are legally cognizable even without revision surgery.
Hernia Mesh (Davol/C.R. Bard) Lawsuit
Hernia mesh litigation is one of the largest ongoing mass tort actions in the United States. Polypropylene mesh devices implanted during inguinal, ventral, and incisional hernia repairs have been associated with a pattern of serious defects — including mesh shrinkage, migration, erosion into adjacent organs, bacterial colonization, and nerve entrapment — that manufacturers knew about for years before disclosing to physicians or patients. The primary defendants include Davol Inc. and its parent C.R. Bard (now part of Becton Dickinson), Ethicon (a Johnson and Johnson subsidiary), Atrium Medical, and Covidien (now part of Medtronic). The federal multidistrict litigation MDL 2846 in the Southern District of Ohio has consolidated thousands of Davol/C.R. Bard claims for coordinated pre-trial proceedings. Separately, Ethicon mesh cases are coordinated in New Jersey Superior Court (MCL 616). Patients who underwent hernia repair surgery and subsequently experienced complications are urged to seek legal evaluation immediately — statutes of limitations are running and evidence must be preserved.
View full case overview